Let's start the conversation...

Call (407) 603-5403 or email growth@legacy-dna.com

Or leave us a note below, and someone senior from Legacy DNA will follow up.

Contact us

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Some leaders prefer to talk things through

Our diagnostic conversation is a focused, strategic conversation designed for executives who want to explore implications, not hear a pitch. It is often used after completing the Scorecard, though that is not required.

Builds on your current reality, not a generic framework

Focuses on commercialization, enterprise value, and exit considerations

Helps determine whether Legacy DNA is the right partner and whether now is the right time

There is no obligation attached. The goal is understanding, not momentum.

Schedule Your Diagnostic Conversation

Get your Exit Readiness Scorecard

If you’re preparing for a future exit, your brand clarity, market position, and growth story can make or break your valuation. The Exit Readiness Scorecard™ reveals where you’re strong, where you're vulnerable, and what to fix before you enter the deal room.

Takes 5-7 minutes

10 questions across 5 valuation domains

Instant score with visual breakdown

Benchmarked against real exits and acquisition standards

Built for healthtech and pharmacy leaders

Start my Exit Readiness Scorecard

Legacy DNA is an enterprise valuation partner for mid-market healthtech and pharmacy companies.

We work with founders, CEOs, and PE operating partners who are navigating growth, scrutiny, and exit pressure at the same time. Our work focuses on helping leadership teams translate complex innovation into clear market narratives, credible growth signals, and buyer-ready stories that stand up to diligence.

Our role is to bring speed, clarity, and impact to moments that matter.

We have been trusted for years by scaling companies across healthtech and pharmacy.

Four successful exits across growth-stage and scaled organizations

Recognized leadership in commercialization and valuation strategy

Author of multiple white papers and books on enterprise value creation in healthtech

Trusted advisors to PE-backed and mid-market leadership teams, and mentors to other startups and healthcare associations

AS SEEN ON...